Tag: IBD
New Hope for Kids with UC: Pfizer’s Oral Therapy Study Results
Pfizer’s new pediatric study of tofacitinib shows promising results for children with ulcerative colitis, offering hope for an oral treatment specifically tested in young patients. This could mean fewer hospital visits, better side effect profiles, and more treatment options designed specifically for our youngest IBD warriors.
New Study Shows 4 in 10 UC Patients Find Real Relief
A real-world study in Sweden shows 40% of ulcerative colitis patients achieved remission with tofacitinib, an oral medication that also reduced fatigue and joint pain. The research offers hope for those seeking alternatives to biologics or struggling with treatment-resistant UC.
When Hope Feels Distant: Understanding AbbVie’s UC Trial News
AbbVie’s ABBV-668 trial for ulcerative colitis didn’t meet its goals, but this setback reveals important insights about UC’s complexity. While disappointing, other promising treatments continue advancing through the research pipeline, offering hope for better options ahead.
Your Gut’s Secret Healing Network Could Transform IBD Treatment
New research reveals that gut neurons produce molecules that help coordinate immune responses and tissue healing in IBD. This discovery could lead to treatments that work with your body’s natural healing mechanisms rather than simply suppressing inflammation.
Beyond Steroids: How Cyclosporin Gives Severe UC Patients New Hope
New 14-year research shows cyclosporin offers hope for severe UC patients when steroids fail, with 88% response rates and rapid remission possible. This could change how we think about rescue therapy options.
Beyond Hope: 90+ New Crohn’s Therapies Could Change Everything
Over 90 new Crohn’s therapies are in development, with some showing remission rates three times higher than current treatments. This unprecedented surge in research could fundamentally change what it means to live with IBD.
Beyond IBD: When Rare Complications Threaten Remission
New research reveals that rare complications like HLH can threaten IBD patients even during remission. Learn what warning signs to watch for and how to discuss these risks with your healthcare team.
When IBD Affects Your Breathing: A Hidden Risk You Should Know
New research reveals people with IBD face nearly 50% higher risk of developing interstitial lung disease. Here’s what this means for your health and how to discuss it with your medical team.
Life After Colectomy: New Hope for Crohn’s Disease of the Pouch
New research shows that two biologic medications, ustekinumab and vedolizumab, offer effective treatment options for people who develop Crohn’s disease of the pouch after ulcerative colitis surgery. This gives hope to patients facing this challenging post-surgical complication.
New Hope for Crohn’s: Targeted Therapy Takes Aim at Root Cause
AstraZeneca’s experimental treatment AZD7798 takes a precision approach to Crohn’s disease, targeting specific immune cells that cause gut inflammation rather than suppressing the entire immune system. This targeted therapy could offer new hope for patients seeking effective treatment with fewer side effects.
